PARIS und WALTHAM (Massachusetts/USA)–(BUSINESS WIRE)–Echosens, ein Hochtechnologieunternehmen und Anbieter der FibroScan®-Produktfamilie, gibt die Veröffentlichung neuer Leitlinien der European Association for the Study of the Liver (EASL) bekannt, eines Fachverbands von…
WALTHAM, Mass.–(BUSINESS WIRE)–Echosens, a high-technology company offering the FibroScan family of products, is pleased to announce that FibroScan has been added to the US Defense Logistics Agency’s Medical Equipment Electronic…
PARIS & WALTHAM, Mass.–(BUSINESS WIRE)–Echosens, ein Hightech-Unternehmen und Anbieter der FibroScan® -Produktfamilie gibt im Rahmen seiner Feierlichkeiten zum 20-jährigen Bestehen erfreut die Ausrichtung des ersten jährlichen „Liver Health Matters Month“…
WALTHAM, Mass.–(BUSINESS WIRE)–Echosens, a high-technology company offering the FibroScan family of products, announces the publication of a peer-reviewed article reporting the findings of an independent assessment conducted by Santa Barbara…
WALTHAM, Mass.–(BUSINESS WIRE)–Echosens, a high-technology company offering the FibroScan family of products, announces its presentation (K7), “Modeling the Return on Investment of VCTE for Fatty Liver Disease (FLD) in a…